| J7Z Stock | | | EUR 116.55 3.40 2.83% |
Insider
Andrea Flynn is VP Relations of Jazz Pharmaceuticals plc
| Phone | 353 1 634 7800 |
| Web | https://www.jazzpharma.com |
Jazz Pharmaceuticals Management Efficiency
The company has return on total asset
(ROA) of
0.053 % which means that it generated a profit of $0.053 on every $100 spent on assets. This is way below average. Jazz Pharmaceuticals' management efficiency ratios could be used to measure how well Jazz Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
Jazz Pharmaceuticals plc has accumulated 6.02
B in total debt with debt to equity ratio
(D/E) of 64.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Jazz Pharmaceuticals plc has a current ratio of 3.09, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Jazz Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Jazz Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Jazz Pharmaceuticals plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Jazz to invest in growth at high rates of return. When we think about Jazz Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. Codiak BioSciences, Inc. Pfenex, Inc. and XL-protein GmbH. JAZZ PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1460 people. Jazz Pharmaceuticals plc (J7Z) is traded on Frankfurt Exchange in Germany and employs 3,200 people.
Management Performance
Jazz Pharmaceuticals plc Leadership Team
Elected by the shareholders, the Jazz Pharmaceuticals' board of directors comprises two types of representatives: Jazz Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jazz. The board's role is to monitor Jazz Pharmaceuticals' management team and ensure that shareholders' interests are well served. Jazz Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jazz Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD, Ex RD | |
| Finbar Larkin, VP Operations | |
| George Eliades, Sr Officer | |
| Daniel Swisher, President COO | |
| Patricia Carr, VP Officer | |
| Heidi Manna, VP Officer | |
| Neena JD, Ex Officer | |
| Renee Gala, Ex CFO | |
| Andrea Flynn, VP Relations | |
| Bruce Cozadd, Chairman of the Board, CEO | |
Jazz Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jazz Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Jazz Stock
When determining whether Jazz Pharmaceuticals plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock: Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, there is a significant difference between Jazz Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jazz Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jazz Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.